Analyst Consensus ?
ConsensusHold25 ratings
Bullish936.0%
Neutral1352.0%
Bearish312.0%
Alexandria Real Estate Equities, Inc. · ARE · FY2024 Q4 · Calendar Q1 2025
ARE: Leasing and capital recycling support a confident outlook
The latest analysis supports a constructive but conditional view: resilient life-science demand, leasing activity and capital recycling provide operating support, while funding conditions, interest rates and execution risks remain material tests for sustained growth.
Reported After market closeNYSEReal Estate
$7.25B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.91
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $779.8M
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-4.8%
Event window
SPY move
+0.9%
Same window
Abnormal move
-5.6%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
+1.9%
Up to 20 sessions
ARESPY benchmark
Ask FN2 about ARE FY2024 Q4
Transcript, numbers and history already loaded
What drove ARE's -4.8% move after FY2024 Q4 earnings?What changed in ARE's guidance and outlook in FY2024 Q4?Give me the bull and bear case for ARE after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the latest call analysis points to continued leasing and capital-recycling momentum, adds explicit attention to wildfire exposure and insurance costs, and keeps guidance sentiment maintained. The development pipeline remains a central growth focus.
Guidance delta
Maintained: management reaffirmed 2025 guidance in the supplied analysis.
Key takeaways
- FFO per share grew 6% year over year in Q4 2024, while revenue and adjusted EBITDA also increased.
- Management cited 5.1 million square feet leased in 2024, with 84% from existing tenant relationships.
- The company reported $1.4 billion of 2024 dispositions, supporting dividend growth and share repurchases.
- Management highlighted a development pipeline that is near-fully leased or under LOI for 2025 and expressed optimism about life-science demand.
Management priorities
- Advance the 2025-2026 development pipeline and pursue targeted lease-up.
- Complete pending dispositions and continue capital recycling.
- Maintain dividend growth and pursue share repurchases within guidance.
- Monitor capital allocation as macroeconomic and regulatory conditions change.
Follow ARE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$41.62Current
$41Low
$69.26Average
$130High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Underweight | Neutral | Downgrade | Sep 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 21, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 24, 2026 |
| Citizens | Market Perform | Market Perform | Maintain | Aug 17, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 10, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 5, 2026 |
| BNP Paribas | Underperform | Underperform | Maintain | Aug 5, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 6, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jun 12, 2026 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Jun 11, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 5, 2026 |
| Jefferies | Hold | Hold | Maintain | Jan 30, 2026 |
| BTIG | Neutral | Buy | Downgrade | Oct 29, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Apr 30, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Dec 6, 2024 |
| B of A Securities | Neutral | Buy | Downgrade | Jul 29, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 20, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 26, 2022 |
| UBS | Neutral | Neutral | Maintain | Oct 16, 2020 |
| Berenberg | Buy | Buy | Maintain | Oct 2, 2020 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jan 14, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Dec 4, 2017 |
| BTIG Research | Buy | Buy | Maintain | Aug 25, 2016 |
| ISI Group | Buy | Neutral | Upgrade | Sep 29, 2014 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $41.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | John Kim | $41 | $45.51 | -1.5% | Oct 12, 2026 |
| RBC Capital | Analyst unavailable | $41 | $45.51 | -1.5% | Oct 12, 2026 |
| Evercore ISI | Analyst unavailable | $59 | $53.3 | +41.8% | Sep 21, 2026 |
| Robert W. Baird | Analyst unavailable | $52 | $53.49 | +24.9% | Aug 24, 2026 |
| Evercore ISI | James Kammert | $57 | $48.14 | +37.0% | Aug 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $52 | $48.04 | +24.9% | Aug 5, 2026 |
| Mizuho Securities | Analyst unavailable | $60 | $51.95 | +44.2% | Jul 6, 2026 |
| BMO Capital | Analyst unavailable | $54 | $53.18 | +29.7% | Jun 12, 2026 |
| Evercore ISI | Analyst unavailable | $58 | $51.96 | +39.4% | Jun 8, 2026 |
| Morgan Stanley | Ronald Kamdem | $53 | $48.22 | +27.3% | May 26, 2026 |
| Goldman Sachs | Julien Blouin | $52 | $46.68 | +24.9% | May 19, 2026 |
| RBC Capital | Analyst unavailable | $50 | $42.32 | +20.1% | May 5, 2026 |
| Evercore ISI | Analyst unavailable | $55 | $41.21 | +32.1% | May 4, 2026 |
| Robert W. Baird | Analyst unavailable | $46 | $41.39 | +10.5% | May 4, 2026 |
| Cantor Fitzgerald | Richard Anderson | $43 | $40.41 | +3.3% | Apr 29, 2026 |
| Morgan Stanley | Analyst unavailable | $54 | $56.62 | +29.7% | Feb 10, 2026 |
| Goldman Sachs | Analyst unavailable | $60 | $54.15 | +44.2% | Feb 3, 2026 |
| Morgan Stanley | Analyst unavailable | $55 | $53.27 | +32.1% | Jan 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $46 | $48.97 | +10.5% | Jan 5, 2026 |
| Deutsche Bank | Omotayo Okusanya | $45 | $47.94 | +8.1% | Dec 19, 2025 |
| Jefferies | Analyst unavailable | $47 | $47.42 | +12.9% | Dec 15, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $48 | $46.84 | +15.3% | Dec 5, 2025 |
| Evercore ISI | Analyst unavailable | $64 | $46.53 | +53.8% | Dec 4, 2025 |
| BMO Capital | John Kim | $60 | $48.42 | +44.2% | Dec 4, 2025 |
| Robert W. Baird | Wesley Golladay | $67 | $48.42 | +61.0% | Dec 4, 2025 |
| Evercore ISI | Analyst unavailable | $72 | $53.84 | +73.0% | Nov 28, 2025 |
| Robert W. Baird | Wesley Golladay | $73 | $52.65 | +75.4% | Nov 26, 2025 |
| Jefferies | Joe Dickstein | $62 | $58.22 | +49.0% | Nov 3, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $79 | $74.09 | +89.8% | Oct 13, 2025 |
| BNP Paribas | Analyst unavailable | $82 | $83.46 | +97.0% | Oct 1, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $88 | $83.34 | +111.4% | Oct 1, 2025 |
| Jefferies | Peter Abramowitz | $105 | $97.55 | +152.3% | Jan 1, 2025 |
| Citigroup | Nick Joseph | $125 | $121.91 | +200.3% | Sep 12, 2024 |
| RBC Capital | Michael Carroll | $130 | $112.14 | +212.3% | Aug 5, 2024 |
| Bank of America Securities | Joshua Dennerlein | $126 | $118.92 | +202.7% | Jul 29, 2024 |
| Evercore ISI | Steve Sakwa | $126 | $115.98 | +202.7% | Jul 25, 2024 |
| Deutsche Bank | Omotayo Okusanya | $140 | $126.01 | +236.4% | Mar 5, 2024 |
| Mizuho Securities | Analyst unavailable | $172 | $133.39 | +313.3% | Jun 23, 2022 |
Track every rating change on ARE the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAlexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® real estate investment trust, stands as the pioneering and most seasoned entity in the specialized domain of urban office properties. Since its inception in 1994, Alexandria has uniquely focused on the ownership, operation, and development of integrated campuses tailored for the life science, technology, and agtech sectors, strategically positioned within premier innovation ecosystems. By December 31, 2020, the company commanded a market capitalization of $31.9 billion and managed an extensive North American asset portfolio totaling 49.7 million square feet. This substantial base encompasses 31.9 million RSF of operational properties, 3.3 million RSF of premium Class A spaces currently under construction, 7.1 million RSF designated for near-to-mid-term development and refurbishment, and an additional 7.4 million SF earmarked for future projects.…
Historical context
All ARE earningsReal Estate peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PLD Prologis, Inc. | FY2026 Q3 · Calendar Q4 2026 | +105.9% | -2.7% | Prologis raises guidance as logistics and data-center demand stays strong |
Latest beats and misses
Who reports nextBeat on EPS
Get the ARE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-13T00:03:16.499918+00:00
- Polygon adjusted daily market bars · 2026-10-19T00:20:44.675866+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T00:20:44.673008+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.